Hepaglide Injection (Semaglutide) (1 Multi-dose Disposable Pen, 4 Needle, 4 Alcohol Swab)
Hepaglide Injection contains Semaglutide, a GLP-1 receptor agonist used to manage type 2 diabetes and support weight loss. It helps regulate blood sugar levels and appetite but requires careful medical supervision due to potential side effects and interactions.
Product Overview
Hepaglide Injection is a used in the management of type 2 diabetes and chronic weight management, offering a multi-pathway approach to regulating blood sugar and appetite. It is an advanced metabolic treatment containing Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is engineered to mimic the natural GLP-1 hormone that the body releases after eating. By enhancing the body's natural insulin response and slowing gastric emptying, Hepaglide helps patients achieve long-term glycemic control and significant metabolic improvements.
Product Composition
The clinical efficacy of Hepaglide is driven by its highly stabilized active ingredient:
- Semaglutide: A long-acting GLP-1 analogue that resists breakdown by the enzyme DPP-4, allowing for sustained activity in the body with a once-weekly dosing schedule.
Product Specification
| Feature | Details |
| Therapeutic Class | GLP-1 Receptor Agonist |
| Administration | Subcutaneous Injection (SC) |
| Primary Indications | Type 2 Diabetes & Chronic Weight Management |
| Dosage Frequency | Once Weekly |
| Delivery System | Pre-filled, 1 Multi-dose Disposable Pen, 4 Needle, 4 Alcohol Swab |
Mechanism of Action
Hepaglide Injection operates through several key physiological mechanisms to improve metabolic health:
- Glucose-Dependent Insulin Secretion: It stimulates the pancreas to release the right amount of insulin when blood sugar levels are high.
- Glucagon Suppression: It reduces the amount of glucagon (a hormone that triggers the liver to release stored sugar) entering the bloodstream, preventing unnecessary blood sugar spikes.
- Gastric Emptying Delay: The medication slows the rate at which food leaves the stomach. This leads to a more gradual absorption of sugar and contributes to a prolonged feeling of fullness.
- Appetite Regulation: Semaglutide acts on specific receptors in the brain that govern hunger and satiety, effectively reducing caloric intake by decreasing cravings and overall appetite.
Key Benefits
- Superior Glycemic Control: Effectively lowers HbA1c levels, helping patients maintain blood sugar within a healthy target range.
- Significant Weight Loss: Clinical data demonstrates that patients often experience meaningful weight reduction when combined with diet and exercise.
- Cardiovascular Protection: Studies indicate that GLP-1 agonists like Semaglutide can reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes.
- Once-Weekly Convenience: The long half-life of the medication allows for a single weekly dose, significantly improving patient adherence compared to daily treatments.
- Simplified Injection Process: The pre-filled pen is designed with a hidden needle and a simple dial-and-click mechanism, making it accessible for patients who may be hesitant about self-injection.
Precautions
Hepaglide Injection (Semaglutide) should be used carefully under medical supervision to ensure safe and effective control of blood sugar and weight management.
Medical Conditions to Inform Your Doctor
| Condition | Why It Matters |
|---|---|
| Pancreatitis history | Semaglutide may increase risk of pancreatic inflammation |
| Thyroid disorders or thyroid cancer history | May increase risk in susceptible patients |
| Severe gastrointestinal disease | Can worsen nausea, vomiting, or delayed gastric emptying |
| Kidney disease | Dehydration from side effects may affect kidney function |
| Liver disease | Requires careful monitoring during treatment |
| Diabetic retinopathy | Blood sugar changes may temporarily worsen eye condition |
Use and Dosing Precautions
- Use exactly as prescribed (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg titration schedule)
- Do not increase dose without doctor supervision
- Administer once weekly on the same day each week
- Rotate injection sites (abdomen, thigh, or upper arm)
Gastrointestinal Effects
- May cause nausea, vomiting, or diarrhea especially during dose escalation
- Eat smaller meals to reduce stomach discomfort
- Stay well hydrated to prevent dehydration
Hypoglycemia Risk
- Risk increases if used with insulin or sulfonylureas
- Monitor blood sugar regularly if combined with other diabetes medicines
Pregnancy and Breastfeeding
- Not recommended during pregnancy
- Should be avoided during breastfeeding unless advised by a doctor
General Advice
- Do not stop suddenly without medical advice
- Store properly as per instructions (usually refrigerated)
- Inform your doctor about all medications you are using
- Regular monitoring of blood sugar and weight is recommended
Usage
Hepaglide Injection is designed for consistent, long-term use and must be administered according to a specific titration schedule to allow the body to adjust to the medication.
Dosage & Administration
The dose is typically started at a low level and increased gradually over several weeks to minimize potential gastrointestinal side effects.
| Aspect | Recommendation |
| Standard Frequency | Once weekly, on the same day each week |
| Administration Site | Subcutaneous (under the skin) in the abdomen, thigh, or upper arm |
| Titration Phase | Dose usually increases every 4 weeks until reaching the maintenance level |
| Missed Dose | Take within 5 days of the missed dose; otherwise, skip and wait for the next scheduled dose |
Administration Protocol
Pen Preparation: Check the solution in the pen; it should be clear and colorless. Attach a new needle for each injection.
Injection Technique: Pinch the skin gently if necessary and insert the needle at a 90-degree angle. Press and hold the button until the dose counter reaches zero, then hold for an additional 5 to 10 seconds to ensure the full dose is delivered.
Rotation: Rotate injection sites with each weekly dose to prevent skin thickening or lumps (lipohypertrophy).
Storage: Store unused pens in the refrigerator. Once in use, the pen can typically be kept at room temperature for up to 56 days.
Uses
Hepaglide Injection is a versatile metabolic regulator used to improve systemic health through hormone-mimicking pathways.
Management of Type 2 Diabetes: It is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Chronic Weight Management: Indicated for long-term weight loss in adults with a body mass index (BMI) classified as obese or overweight with at least one weight-related condition (such as high blood pressure or high cholesterol).
Cardiovascular Risk Reduction: Used to reduce the risk of major adverse cardiovascular events (including heart attack and stroke) in adults with type 2 diabetes and established cardiovascular disease.
HbA1c Reduction: Helps in lowering and stabilizing A1c levels, which is a critical marker for long-term blood sugar management.
Appetite Suppression: Utilized to help patients adhere to calorie-restricted diets by targeting the brain's hunger centers and slowing digestion.
Side Effects
Hepaglide Injection (Semaglutide) may cause side effects, especially during the initial dose escalation period. Most effects are mild to moderate and tend to improve over time.
Common Side Effects
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain or discomfort
- Loss of appetite
- Indigestion
Less Common Side Effects
- Dizziness
- Fatigue
- Bloating
- Acid reflux
- Injection site reactions (redness, swelling, or itching)
Serious Side Effects
| Serious Condition | Symptoms |
|---|---|
| Pancreatitis | Severe abdominal pain, vomiting, pain radiating to back |
| Severe hypoglycemia | Sweating, confusion, shakiness, fainting |
| Gallbladder problems | Upper abdominal pain, fever, yellowing of skin or eyes |
| Severe dehydration | Very low urine output, dizziness, extreme thirst |
| Allergic reaction | Rash, swelling of face/lips, breathing difficulty |
Important Advice
- Side effects are more common when starting or increasing the dose
- Eat smaller meals to reduce nausea and stomach discomfort
- Stay well hydrated to prevent dehydration
- Report severe or persistent symptoms to a doctor immediately
| Manufacturer | : | Alkem Laboratories Ltd |
| Trade Name | : | Ozempic |
| Generic Search | : | Semaglutide |
| Strength | : | 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg |
Latest Products
